BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35430320)

  • 1. Fusion HBx from HBV integrant affects hepatocarcinogenesis through deregulation of ER stress response.
    Muroyama R; Nakagawa R; Matsubara Y; Hirata Y; Omata M; Shirasawa H; Kato N
    Virus Res; 2022 Jul; 315():198787. PubMed ID: 35430320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism.
    Zhang Y; Yan Q; Gong L; Xu H; Liu B; Fang X; Yu D; Li L; Wei T; Wang Y; Wong CN; Lyu Z; Tang Y; Sham PC; Guan XY
    Oncogene; 2021 Feb; 40(6):1147-1161. PubMed ID: 33323975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboxyl-terminal truncated HBx contributes to invasion and metastasis via deregulating metastasis suppressors in hepatocellular carcinoma.
    Li W; Li M; Liao D; Lu X; Gu X; Zhang Q; Zhang Z; Li H
    Oncotarget; 2016 Aug; 7(34):55110-55127. PubMed ID: 27391153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis.
    Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E
    Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A positive-feedback loop between HBx and ALKBH5 promotes hepatocellular carcinogenesis.
    Qu S; Jin L; Huang H; Lin J; Gao W; Zeng Z
    BMC Cancer; 2021 Jun; 21(1):686. PubMed ID: 34112124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis.
    Zhang T; Zhang J; Cui M; Liu F; You X; Du Y; Gao Y; Zhang S; Lu Z; Ye L; Zhang X
    Neoplasia; 2013 Nov; 15(11):1282-91. PubMed ID: 24339740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBx Protein Contributes to Liver Carcinogenesis by H3K4me3 Modification Through Stabilizing WD Repeat Domain 5 Protein.
    Gao W; Jia Z; Tian Y; Yang P; Sun H; Wang C; Ding Y; Zhang M; Zhang Y; Yang D; Tian Z; Zhou J; Ruan Z; Wu Y; Ni B
    Hepatology; 2020 May; 71(5):1678-1695. PubMed ID: 31544250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
    Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
    J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bufalin inhibits hepatitis B virus-associated hepatocellular carcinoma development through androgen receptor dephosphorylation and cell cycle-related kinase degradation.
    Yu Z; Feng H; Zhuo Y; Li M; Zhu X; Huang L; Zhang X; Zhou Z; Zheng C; Jiang Y; Le F; Yu DY; Cheng AS; Sun X; Gao Y
    Cell Oncol (Dordr); 2020 Dec; 43(6):1129-1145. PubMed ID: 32623699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma.
    Ali A; Abdel-Hafiz H; Suhail M; Al-Mars A; Zakaria MK; Fatima K; Ahmad S; Azhar E; Chaudhary A; Qadri I
    World J Gastroenterol; 2014 Aug; 20(30):10238-48. PubMed ID: 25132741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular antibody targeting HBx suppresses invasion and metastasis in hepatitis B virus-related hepatocarcinogenesis via protein phosphatase 2A-B56γ-mediated dephosphorylation of protein kinase B.
    Che L; Du ZB; Wang WH; Wu JS; Han T; Chen YY; Han PY; Lei Z; Chen XX; He Y; Xu L; Lin X; Lin ZN; Lin YC
    Cell Prolif; 2022 Nov; 55(11):e13304. PubMed ID: 35811356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus X protein-induced SH2 domain-containing 5 (SH2D5) expression promotes hepatoma cell growth via an SH2D5-transketolase interaction.
    Zheng Y; Ming P; Zhu C; Si Y; Xu S; Chen A; Wang J; Zhang B
    J Biol Chem; 2019 Mar; 294(13):4815-4827. PubMed ID: 30659097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.
    Ching RHH; Sze KMF; Lau EYT; Chiu YT; Lee JMF; Ng IOL; Lee TKW
    Oncotarget; 2017 Apr; 8(14):23507-23516. PubMed ID: 28186991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus whole-X and X protein play distinct roles in HBV-related hepatocellular carcinoma progression.
    Zhang Y; Liu H; Yi R; Yan T; He Y; Zhao Y; Liu J
    J Exp Clin Cancer Res; 2016 Jun; 35(1):87. PubMed ID: 27255760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
    Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
    Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
    Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus X protein accelerates hepatocarcinogenesis with partner survivin through modulating miR-520b and HBXIP.
    Zhang W; Lu Z; Kong G; Gao Y; Wang T; Wang Q; Cai N; Wang H; Liu F; Ye L; Zhang X
    Mol Cancer; 2014 May; 13():128. PubMed ID: 24886421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis.
    Dang S; Zhou J; Chen Y; Chen P; Ji M; Shi B; Yang Q; Hou P
    Oncogene; 2019 Jun; 38(24):4804-4819. PubMed ID: 30804458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus X protein promotes hepatocarcinogenesis via the activation of HMGA2/STC2 signaling to counteract oxidative stress-induced cell death.
    Huang FY; Wong DK; Mak LY; Cheung TT; Seto WK; Yuen MF
    Carcinogenesis; 2022 Aug; 43(7):671-681. PubMed ID: 35353897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.